`
`
`Paper 23
`Date: December 11, 2023
`
`Trials@uspto.gov
`571-272-7822
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MEDIVIS, INC.,
`Petitioner,
`
`v.
`
`NOVARAD CORP.,
`Patent Owner.
`____________
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)1
`____________
`
`
`
`Before MIRIAM L. QUINN, MICHAEL R. ZECHER, and
`SCOTT RAEVSKY, Administrative Patent Judges.
`
`RAEVSKY, Administrative Patent Judge.
`
`
`
`
`
`ORDER
`Granting In Part Patent Owner’s Request to File Exhibits
`37 C.F.R. § 42.5(a)
`
`
`
`1 The Board exercises its discretion to mail the same Order in both of these
`proceedings. The parties are not authorized to use this caption format.
`
`
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)
`
`
`
`On December 5, 2023, the Board held a telephone conference with the
`parties to discuss Patent Owner’s request to file exhibits which Patent Owner
`intended to file with its Sur-replies in IPR2023-00042 (Paper 22) and
`IPR2023-00045 (Paper 22). See Ex. 3001. Judges Quinn, Zecher, and
`Raevsky participated on behalf of the Board.
`In IPR2023-00042, Patent Owner requests to submit the following
`exhibits:
`(1) Declaration of Page Vault Representative Todd W. Price (May 19,
`2023) (“Price Declaration”), which includes a copy of Amira 5
`User’s Guide (Visual Imaging 2009) (“Amira”);
`(2) Dr. Rosenberg Supplemental Declaration (referenced as Exhibit
`2008 in Paper 22); and
`(3) Dr. Mulumudi Supplemental Declaration (referenced as Exhibit
`2009 in Paper 22).
`In IPR2023-00045, Patent Owner requests to submit the Price
`Declaration and the Dr. Mulumudi Supplemental Declaration (referenced as
`Exhibit 2005 in Paper 22).
`
`Price Declaration
`We first address the Price Declaration. During the call, we noted that
`the Price Declaration is already of record in IPR2023-00042 as Exhibit
`1023. Patent Owner therefore agreed that there is no need to refile the Price
`Declaration in the -00042 case and amended its request to file the Price
`Declaration solely in the -00045 case. See 37 C.F.R. § 42.6(d). Patent
`Owner explained that the copy of Amira in the Price Declaration is the entire
`reference, whereas the copy of Amira filed as Exhibit 1005 only includes
`two chapters of the reference. Patent Owner had planned to file a motion to
`
`
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)
`
`
`exclude the incomplete version of Amira of Exhibit 1005, and to argue in the
`alternative that the Board should allow Patent Owner to file the full copy of
`Amira in Exhibit 1023. However, as the parties’ arguments continued, with
`no objection from Petitioner to include the Price Declaration in the -00045
`case, Patent Owner stated that a motion to exclude Exhibit 1005 would not
`be needed if the Price Declaration would be allowed in the record.
`Furthermore, considering how Amira bears on the issues presented
`and developed by the parties in the -00045 case, the panel notes it will be
`beneficial to have the Price Declaration with a full copy of Amira.
`Consequently, because Petitioner does not object to Patent Owner’s request
`to include the Price Declaration in the -00045 case, and it would be
`beneficial to the Board, we grant Patent Owner’s request to submit the Price
`Declaration as a 2000-series exhibit in IPR2023-00045.
`Drs. Rosenberg and Mulumudi Supplemental Declarations
`Now we turn to whether we allow Patent Owner to file the
`supplemental declarations of Drs. Rosenberg and Mulumudi, cited as new
`evidence in the sur-reply. After hearing the parties’ arguments, we deny
`Patent Owner’s request to submit the Dr. Rosenberg Supplemental
`Declaration (in the -00042 case) and the Dr. Mulumudi Supplemental
`Declarations (in both cases).
`It is well established that “[a] sur-reply may only respond to
`arguments raised in the corresponding reply and may not be accompanied by
`new evidence other than deposition transcripts of the cross-examination of
`any reply witness.” 37 C.F.R. § 42.23(b). Although we have the authority to
`waive this rule, Patent Owner does not persuade us to do so for these
`declarations. See id. § 42.5(b) (“The Board may waive or suspend a
`
`
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)
`
`
`requirement of parts 1, 41, and 42 and may place conditions on the waiver or
`suspension.”).2 On the call, Patent Owner argued that the Dr. Rosenberg
`Supplemental Declaration and the Dr. Mulumudi Supplemental Declarations
`address Petitioner’s arguments in the Reply concerning the qualifications of
`these declarants. We determine that it is unnecessary for Patent Owner to
`present new evidence of qualification of its declarations via these
`declarations for us to assess the merits of Petitioner’s arguments raised in the
`Reply. At a minimum, we are able to assess the qualifications of these
`declarants based on their curricula vitae already submitted by Patent Owner
`(IPR2023-00042, Exs. 2003 & 2005; IPR2023-00045, Ex. 2003). And the
`inclusion of this new evidence would raise concerns of expanding discovery
`and briefing unnecessarily, given that (1) we are capable of determining
`what weight to afford the declarants’ testimony based on the sufficiency of
`their testimony and (2) exclusion of evidence is determined based on a
`proper motion to exclude.
`Should Petitioner subsequently file a proper motion to exclude Dr.
`Rosenberg or Dr. Mulumudi’s original declarations based on their
`qualifications, Patent Owner may at that time choose to file these
`declarations with its opposition to Petitioner’s motion to exclude. See 37
`C.F.R. § 42.64(b)(2) (“The party relying on evidence to which an objection
`is timely served may respond to the objection by serving supplemental
`evidence within ten business days of service of the objection.”);
`Consolidated Trial Practice Guide 79, available at
`
`
`2 Note that we are exercising our authority under Rule 42.5 to permit Patent
`Owner to file the Price Declaration.
`
`
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)
`
`
`https://www.uspto.gov/TrialPracticeGuideConsolidated (“Supplemental
`evidence is not filed at the time of the objection, but simply served, and is
`filed only in support of an opposition to a motion to exclude.”).
`
`It is, therefore,
`ORDERED that Patent Owner’s request to file the Price Declaration
`as a 2000-series exhibit in IPR2023-00045 is granted; and
`FURTHER ORDERED that Patent Owner’s request to file
`supplemental declarations in IPR2023-00042 and IPR2023-00045 as new
`evidence supporting the Patent Owner Sur-reply is denied.
`
`
`
`IPR2023-00042 (Patent 11,004,271 B2)
`IPR2023-00045 (Patent 10,945,807 B2)
`
`
`FOR PETITIONER
`Kia L. Freeman
`John Curran
`MCCARTER & ENGLISH, LLP
`kfreeman@mccarter.com
`jcurran@mccarter.com
`
`FOR PATENT OWNER
`Joseph Harmer
`Jed H. Hansen
`THORPE NORTH & WESTERN LLP
`joseph.harmer@tnw.com
`hansen@tnw.com
`
`